Specialty |
| June | July | August | September | October | November | December |
Cardiology |
|
|
|
|
|
|
|
|
| Number of interventions | 45 | 62 | 41 | 44 | 79 | 129 | 98 |
| Number of affected doses | 104 | 160 | 93 | 151 | 279 | 217 | 158 |
| Resistance rate | 33% | 31% | 24% | 18% | 23% | 31% | 23% |
Hepatology |
|
|
|
|
|
|
|
|
| Number of interventions | 10 | 14 | 5 | 18 | 11 | 36 | 24 |
| Number of affected doses | 67 | 22 | 17 | 103 | 49 | 111 | 47 |
| Resistance rate | 20% | 50% | 0% | 17% | 0% | 11% | 21% |
ICU |
|
|
|
|
|
|
|
|
| Number of interventions | 73 | 58 | 58 | 219 | 87 | 99 | 85 |
| Number of affected doses | 267 | 65 | 109 | 526 | 259 | 163 | 88 |
| Resistance rate | 14% | 29% | 43% | 16% | 14% | 16% | 28% |
Internal Medicine |
|
|
|
|
|
|
|
|
| Number of interventions | 44 | 36 | 18 | 32 | 26 | 69 | 27 |
| Number of affected doses | 136 | 76 | 32 | 63 | 97 | 146 | 41 |
| Resistance rate | 16% | 33% | 33% | 16% | 15% | 20% | 30% |
Nephrology |
|
|
|
|
|
|
|
|
| Number of interventions | 5 | 8 | 3 | 9 | 15 | 8 | 5 |
| Number of affected doses | 3 | 8 | 0 | 43 | 47 | 13 | 15 |
| Resistance rate | 60% | 50% | 8% | 0% | 20% | 25% | 40% |
Neurology |
|
|
|
|
|
|
|
|
| Number of interventions | 7 | 21 | 13 | 8 | 20 | 22 | 21 |
| Number of affected doses | 2 | 70 | 25 | 35 | 69 | 61 | 38 |
| Resistance rate | 71% | 14% | 23% | 25% | 10% | 23% | 29% |
Obstetrics and Gynecology |
|
|
|
|
|
|
|
|
| Number of interventions | 12 | 6 | 7 | 19 | 42 | 36 | 32 |
| Number of affected doses | 65 | 12 | 4 | 54 | 76 | 61 | 43 |
| Resistance rate | 0% | 50% | 71% | 21% | 14% | 6% | 13% |
Oncology |
|
|
|
|
|
|
|
|
| Number of interventions | 8 | 18 | 4 | 6 | 6 | 2 | 2 |
| Number of affected doses | 48 | 34 | 22 | 22 | 19 | 3 | 10 |
| Resistance rate | 0% | 39% | 25% | 0% | 0% | 0% | 0% |
Opthalmology |
|
|
|
|
|
|
|
|
| Number of interventions | 3 | 0 | 0 | 1 | 0 | 1 | 0 |
| Number of affected doses | 9 | 0 | 0 | 2 | 0 | 0 | 0 |
Orthopedics |
|
|
|
|
|
|
|
|
| Number of interventions | 15 | 18 | 6 | 21 | 19 | 35 | 36 |
| Number of affected doses | 43 | 30 | 7 | 59 | 87 | 119 | 62 |
| Resistance rate | 13% | 50% | 33% | 24% | 26% | 20% | 3% |